Suppr超能文献

利用联合尿激素和智能手机技术帮助患者预测和确认排卵:概念验证回顾性描述性病例系列。

Helping Patients to Predict and Confirm Ovulation with the Use of Combined Urinary Hormonal and Smartphone Technology: A Proof-of-Concept Retrospective Descriptive Case Series.

机构信息

Department of Family Medicine, Bruyere Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

Hospices Civils de Lyon, Universite de Lyon, Lyon, France.

出版信息

Semin Reprod Med. 2024 Jun;42(2):90-99. doi: 10.1055/s-0044-1791702. Epub 2024 Oct 8.

Abstract

Smartphone-based fertility awareness methods with home-based urinary hormonal testing are gaining popularity for fertility tracking. In our university-affiliated family practice, we integrated a previously developed ovulation tracking application into a protocol for monitoring urinary sex hormones and cervical secretions. Serum progesterone was used to confirm the luteal phase, with levels ≥ 15.9 nmol/L ensuring confirmation. Data from 110 women seen for infertility treatment ( = 95) or family planning advice ( = 15) and using our ovulation prediction protocol showed that most opted for a combination of cervical mucus and luteinizing hormone testing ( = 86). Among those using it for family planning, the median usage among women spanned 56 cycles, and 13 cycles per woman required progesterone testing for confirmation. Thirteen patients are still using the method without unintended pregnancies. No unintended pregnancies occurred. Confidence in tests based on serum progesterone was high (93%). For infertility, the method helped in the identification of anovulation, evaluating treatment response, and in diagnosing subfertility causes. This proof-of-concept retrospective descriptive case series suggests the potential for smartphone-based monitoring in fertility management, urging further studies for application enhancements and prospective validation.

摘要

基于智能手机的生育能力感知方法与家庭尿液激素检测相结合,正在成为生育跟踪的热门选择。在我们大学附属医院的家庭诊所中,我们将之前开发的排卵跟踪应用程序整合到监测尿液性激素和宫颈分泌物的方案中。血清孕激素用于确认黄体期,水平≥15.9 nmol/L 即可确认。我们对 110 名接受不孕治疗(n=95)或计划生育咨询(n=15)并使用我们的排卵预测方案的女性的数据进行了分析,结果显示,大多数女性选择了联合宫颈黏液和促黄体生成素检测(n=86)。在那些使用该方法进行计划生育的女性中,中位数使用周期为 56 个周期,每个女性需要进行 13 个周期的孕激素检测以确认。目前有 13 名患者仍在使用该方法,且未出现意外怀孕。未发生意外怀孕。基于血清孕激素的检测方法具有较高的可信度(93%)。对于不孕患者,该方法有助于确定无排卵、评估治疗效果,并诊断生育能力低下的原因。这项基于智能手机的生育能力监测的概念验证回顾性描述性病例系列研究表明,该方法在生育管理方面具有潜在的应用前景,需要进一步的研究以增强应用并进行前瞻性验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb36/11581822/423663bf2e92/10-1055-s-0044-1791702-i2400012-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验